FUJIFILM Sonosite Introduces the All-Touchscreen Sonosite ST POCUS System, Designed and Engineered to Support Procedural Workflows


BOTHELL, Wash., July 03, 2023 (GLOBE NEWSWIRE) — FUJIFILM Sonosite, Inc. – The world leader in point-of-care ultrasound (POCUS) solutions has added to its leading portfolio of systems with the launch of the Sonosite ST. Designed with the busy proceduralist in mind, Sonosite ST offers a new 21-inch all-touchscreen interface, a large 10” by 7.5” image area, automated setting optimisation for each investigation type, Auto Steep Needle Profiling (SNP) and more. Sonosite ST also shares the same family of transducers with Sonosite PX and Sonosite LX to support compatibility across systems.

‘As the company that invented POCUS we’ve spent the last 25 years working with clinical customers to innovate and advance the use of ultrasound at the patient’s bedside,’ said FUJIFILM Sonosite President and CEO Rich Fabian. ‘That collaboration has once again delivered results in the form of a system designed for proceduralists, something engineered to help them save time, increase confidence and improve outcomes.’

‘At a time when hospitals are facing unprecedented clinical staffing challenges, we believe the Sonosite ST has the potential to improve both the clinician and patient experience, while at the same time enabling increased throughput,’ Fabian said. ‘I’m very confident the Sonosite ST will become an industry workhorse for procedure-focused clinicians,’ Fabian added.


The Sonosite ST features optimised investigation types for the POCUS-guided procedures used most often, including nerve block administration in regional anaesthesia, vascular access in emergency medicine and joint injections in musculoskeletal care. This enables proceduralists to rapidly select the appropriate investigation type for their procedure at the touch of a button, allowing them to access the most needed optimisations, annotations and callipers to simplify their workflow.

‘The value of POCUS has been clearly demonstrated in my care delivery and I’m thrilled to see it becoming standard practice for needle-based interventions across a variety of healthcare specialisms including anaesthesia, vascular and musculoskeletal care, and beyond,’ says anaesthetist, Dr David Auyong. ‘I look forward to using Fujifilm’s new Sonosite ST, which will take the value of POCUS-guidance a step further for proceduralists by prioritising and streamlining access to critical investigation types with amazing image clarity.’

As with all FUJIFILM Sonosite POCUS systems, the Sonosite ST is built to legendary durability, reliability and ease-of-use standards. The ultrasound transducers are drop-tested to one metre and the work surface is sealed to the edge for simplified cleaning and disinfection. FUJIFILM Sonosite also provides an industry-leading five-year warranty, which reduces cost of ownership over time.

Find out more about the Sonosite ST by visiting https://www.sonosite.com/products/sonosite-st.

About FUJIFILM Sonosite

FUJIFILM Sonosite, Inc. is the innovator and world leader in bedside and point-of-care ultrasound, and an industry leader in ultra-high-frequency micro-ultrasound technology. With its headquarters near Seattle, the company is represented by a global distribution network in over 100 countries. Sonosite’s portable, compact systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care. For more information, please visit www.sonosite.com

FUJIFILM Holdings Corporation, Tokyo, leverages its depth of knowledge and proprietary core technologies to deliver ‘Value from Innovation’ in our products and services in the business segments of healthcare, materials, business innovation and imaging. Our relentless pursuit of innovation is focused on providing social value and enhancing the lives of people worldwide. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship. For more information about Fujifilm’s Sustainable Value Plan 2030, click here. For the year ending 31 March 2023, the company had global revenues of approximately 2.9 trillion yen (21 billion USD at an exchange rate of 134 yen/dollar). For more information, please visit: www.fujifilmholdings.com.


Todd Langton 
Corporate Communications Manager 
FUJIFILM Sonosite 
[email protected] 
+1 425 381 9290 (mobile) 

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. AfternoonHeadlines.com takes no editorial responsibility for the same.